Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

Registration NOW open for the Best of ASRM and ESHRE 2025 !

Update of the Evidence based guideline on Premature Ovarian Insufficiency – now published

25 October 2024

Premature Ovarian Insufficiency (POI) presents a significant challenge to women's health, with far-reaching implications, both physically and emotionally. To improve the care of women with POI, an international expert group, including representation from ESHRE, ASRM, CRE-WHiRL and IMS collaborated to address 40 key questions through 145 recommendations.
For professionals involved in the care for women with POI, this is a must-read document.

PGT troubleshooting from intake to follow-up seminar - join the 2024 edition

26 September 2024

This comprehensive seminar will help guide professionals through the different steps of the Preimplantation Genetic Testing (PGT) process, from the initial intake of patients to successful post-procedure follow-up.

Women with premature ovarian insufficiency are at greater risk of severe autoimmune diseases

26 September 2024

Human Reproduction Press Release
Severe autoimmune conditions such Type I diabetes, Addison’s disease, lupus and inflammatory bowel disease, are between two to three times more common in women who have been diagnosed with premature ovarian insufficiency (POI) compared to the general population.

ESGO-ESHRE-ESGE guidelines for fertility-sparing in gynecologic cancer now published

30 August 2024

The European Society of Gynaecological Oncology, the European Society of Human Reproduction and Embryology, and the European Society for Gynaecological Endoscopy jointly developed clinically relevant and evidence-based guidelines focusing on key aspects of fertility-sparing strategies and follow-up of patients with cervical cancers, ovarian cancers, and borderline ovarian tumours.